Each rheumatologist’s path to the specialty is unique. Here, three practicing rheumatologists share what inspired them to become rheumatologists, what brings them fulfillment and how to bring others into the specialty…

Each rheumatologist’s path to the specialty is unique. Here, three practicing rheumatologists share what inspired them to become rheumatologists, what brings them fulfillment and how to bring others into the specialty…
Once the barriers to telemedicine are overcome, this modern approach to the practice of medicine solves patient access issues and increases physician productivity, says Daniel Albert, MD, a pediatric rheumatologist at the Center for Telehealth at Dartmouth-Hitchcock Medical Center…
Simon M. Helfgott, MD |
Which came first? The infectious microorganism or a host’s immune resistance against it? Through the millennia, a raging battle has pitted the hordes of infectious agents surrounding us against, arguably, the most complex biologic structure ever created, the finely tuned human immune system. The stakes are high for both sides. For the infectious agent, an…
Brandon Young, DNP, FNP-C, RN-C, & Catherine Figueroa, BSN, RN, submitted on behalf of the ARHP Practice Committee |
A patient presents at her rheumatologist’s office for a visit and is greeted by a certified medical assistant (CMA), who obtains vital signs, gathers health information and updates pertinent information that may have changed since the prior visit. The CMA is one of many healthcare providers who may be involved in the care of rheumatology…
Rheumatology nurses have a new option to obtain certification. Instead of taking an exam to demonstrate one’s competencies, rheumatology nurses can provide documentation of their expertise through an online application process, the American Nurses Credentialing Center’s (ANCC) Rheumatology Nursing Certification Through Portfolio. Launched in February 2016, the program was developed by the ANCC in collaboration…
Two sets of guidelines—one on managing anti-rheumatic drugs perioperatively for patients undergoing total hip and knee replacements, and another that updates glucocorticoid-induced osteoporosis prevention and treatment strategies—will be featured in sessions at the 2016 ACR/ARHP Annual Meeting this month. The Sessions Sunday, Nov. 13, 2:30–3:30 p.m.: Glucocorticoid-Induced Osteoporosis Prevention and Treatment: A New ACR Clinical…
Will Boggs, MD |
NEW YORK (Reuters Health)—Gene expression and chromatin accessibility can be used to identify two Crohn’s disease (CD) molecular subclasses that match distinct disease phenotypes, researchers report. “The hope one day is to be able to test Crohn’s patients for the subtype of the disease they have, and thus determine which treatment should work best,” Dr….
Will there be enough rheumatology clinicians available to treat a growing patient population in the future? Not unless serious steps are taken now, according to the American College of Rheumatology’s 2015 Workforce Study of Rheumatology Specialists in the United States. The study’s complete findings will be presented at a panel discussion session at the 2016…
During an interactive, case-based course at the 2016 ACR/ARHP Annual Meeting, participants will develop strategies to help patients manage unique barriers to access to care and adherence…
Abaloparatide for Osteoporosis Abaloparatide is completing Phase III clinical trials for the potential treatment of postmenopausal osteoporosis in women who are at an increased risk of fracture.1 Abaloparatide is a synthetic peptide that engages the parathyroid hormone receptor and has favorable bone building activity. Abaloparatide has completed Phase 3 development for use as a daily…